Radial Extracorporeal Shock Wave Therapy for Chronic Non-specific Low Back Pain

Completed 150 enrolled First Affiliated Hospital of Zhejiang University Ludwig-Maximilians - University of Munich · collab

RandomizedParallel-groupSingle-blindTreatment

Summary

This study tests the hypothesis that radial extracorporeal shock wave therapy (rESWT) in combination with the non-steroidal anti-inflammatory drug Celecoxib and the antispasmodic drug Eperisone (hereafter, "C-E drug therapy") is statistically significantly more effective than either rESWT or C-E drug therapy alone in the treatment of chronic non-specific low back pain.

Timeline

Start: 2017-11-13
Primary completion: 2019-04-05
Completion: 2019-08-01

Publications

Guo X, Li L, Yan Z, Li Y, Peng Z, Yang Y, Zhang Y, Schmitz C, Feng Z. Efficacy and safety of treating chronic nonspecific low back pain with radial extracorporeal shock wave therapy (rESWT), rESWT combined with celecoxib and eperisone (C + E) or C + E alone: a prospective, randomized trial. J Orthop Surg Res. 2021 Dec 4;16(1):705. doi: 10.1186/s13018-021-02848-x.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Celecoxib	Other / unclassified	200 mg	—
Comparator	Eperisone	Small molecule	50 mg	—

Indications

No indication recorded.